Discovering a new drug is only the beginning: progress and challenges in expanding access to BDQ for MDR-TB treatment

Int J Tuberc Lung Dis. 2020 Oct 1;24(10):985-986. doi: 10.5588/ijtld.20.0562.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Diarylquinolines
  • Humans
  • Pharmaceutical Preparations*
  • Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

  • Antitubercular Agents
  • Diarylquinolines
  • Pharmaceutical Preparations